Kellogg Co
Change company Symbol lookup
Select an option...
K Kellogg Co
$NQUSM30201030EURT Nasdaq Mid Cap Financial Data Provid
MORF Morphic Holding Inc
STOK Stoke Therapeutics Inc
DUOT Duos Technologies Group Inc
BCLI Brainstorm Cell Therapeutics Inc
EEX Emerald Holding Inc
JPM-L JPMorgan Chase & Co
SBFM Sunshine Biopharma Inc
SEKEY Seiko Epson Corp

Consumer Staples : Food Products | Mid Cap Value
Company profile

Kellogg Company is a United States-based company which is engaged in manufacturing and marketing of snacks and convenience foods. The Company’s segments include North America, Europe, Latin America, and AMEA (Asia Middle East Africa). Its principal products are snacks, which includes crackers, savory snacks, toaster pastries, cereal bars, granola bars and bites, and convenience foods, which include ready-to-eat cereals, frozen waffles, veggie foods and noodles. The Company’s snacks brands are marketed under brands, such as Kellogg’s, Cheez-It, Pringles, Austin, Parati and RXBAR. Its cereals and cereal bars are generally marketed under Kellogg’s name, with some under the Kashi & Bear Naked brands. The Company’s frozen foods are marketed under the Eggo and Morningstar Farms brands. It uses broker and distributor arrangements for certain products and channels, as well as in certain geographies. The Company has manufactured in over 21 countries and marketed in approximately 180 countries.

Closing Price
Day's Change
-0.72 (-1.20%)
B/A Size
Day's High
Day's Low

10-day average volume:

Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset

9:00 pm ET August 3, 2023 (BusinessWire) Print

Certara, Inc. (Nasdaq: CERT), a global leader in Biosimulation, today announced that a Korea Institute of Toxicology (KIT) have decided to implement Certara's Pinnacle 21 Enterprise data conformance and submission software and SEND Explorer pre-clinical data visualization software . The combination of Pinnacle 21 Enterprise and SEND Explorer enables synergy for meeting global regulatory guidelines and delivering efficiency. The technology optimizes data analysis from a regulatory perspective and allows scientists to gain scientific insight through interactive toxicity data visualization. It also ensures FDA submission-ready SEND, SDTM, and ADaM datasets.

Pinnacle 21 Enterprise is used to validate compliance with the Clinical Data Interchange Standards Consortium (CDISC) standards, which are required by the U.S. Food & Drug Administration (FDA), Japan's Pharmaceuticals and Medical Devices Agency (PMDA), and recommended by China's National Medical Products Administration (NMPA) for evaluating regulatory submissions. Pinnacle 21 Enterprise software has been adopted by the FDA and PMDA as well as 24 of the top 25 biopharmaceutical companies by R&D spend.

SEND Explorer is a validated, web-based application that provides advanced viewing, data summarization and visualization capabilities for nonclinical study data. Using SEND Explorer, scientists generate visualizations of single and multiple toxicology studies to inform decisions and quickly address questions from health authorities.

"We expect that using Pinnacle 21 Enterprise will help KIT increase the quality of SEND Datasets for submission to regulatory agencies. In addition, SEND Explorer will help KIT provide advanced analysis including historical data and cross-analysis studies of toxicity tests, that enable sponsors to quickly address questions from the FDA." said Junyong Lee, Korea Country Sales Director at Certara.

"With SEND Explorer and Pinnacle 21 Enterprise, scientists can more effectively bridge the translational gap between the nonclinical and clinical phases and ensure that they are regulatory ready" added Leif E. Pedersen, President, Software at Certara.

Learn more about Certara software:

About Certara

Certara accelerates medicines using proprietary biosimulation software, technology and services that transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.

View source version on

SOURCE: Certara

Emi Akatsu
comtex tracking


Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.